Naweitech: Blood products are listed as a key application direction in the core business of chromatography fillers.

On September 22nd, Nawei Technology disclosed the investor relations activity record form. Nawei Technology stated that in recent years, domestic blood product customers have been paying more attention to innovative process research and domestic substitutes for key materials. The company has included blood products as one of the key application directions in the company's chromatographic filler core business "3+2", continuously developing new products and application processes, actively addressing customer needs, and importing research and development projects at different stages.